Rifampicin use in MRSA infections: will it add to the emergence of multidrug-resistant tuberculosis in developing countries?

Subjects

Subjects :

Humans
Tuberculosis, Multidrug-Resistant etiology
Antibiotics, Antitubercular therapeutic use
Developing Countries
Methicillin-Resistant Staphylococcus aureus drug effects
Rifampin therapeutic use
Staphylococcal Infections drug therapy
Tuberculosis, Multidrug-Resistant epidemiology

Details

Language :

English

ISSN :

1341-321X

Volume :

15

Issue :

3

Database :

MEDLINE

Journal :

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Publication Type :

Editorial & Opinion

Accession number :

19554408

Full Text :

https://doi.org/10.1007/s10156-008-0641-0